Sunday, May 5, 2024

Johnson & Johnson to continue selling baby powder in UK

Date:

Share post:

London – Healthcare giant Johnson & Johnson says it will continue to sell its talc-based Johnson’s Baby Powder in the UK and the rest of the world, despite stopping sales in the US and Canada.

It said North American sales had shrunk partly because of a “constant barrage” of advertising by lawyers seeking clients to claim against the company.

J&J has been at the centre of claims for years that its talc causes cancer.

It has always strenuously defended the product’s safety.

Johnson & Johnson has been ordered to pay out billions of dollars in compensation, but has so far always successfully appealed against these verdicts.

Almost 20 000 people in the US have so far lodged claims against the company.

Talc is mined from the earth and is found in seams close to that of asbestos, a material known to cause cancer.

The company said in a statement: “Johnson & Johnson remains steadfastly confident in the safety of talc-based Johnson’s Baby Powder.”

It said “decades” of study by medical and legal experts around the world supported its view, and all verdicts against the company that had gone against it had been overturned on appeal.

Dampened demand

It will continue to sell its talc-based products in the US and Canada until stocks have sold out.

It also sells a cornstarch-based powder that it will continue to sell in North America.

It said both types of Johnson’s baby powder, talc-based and cornstarch-based, will continue to be sold in other markets around the world where there is “significantly higher” consumer demand for the product.

The firm said changes in consumer behaviour had also dampened demand for the powder.

The firm added that the move was also part of a reassessment of its consumer products prompted by the novel coronavirus (COVID-19) pandemic.

It said in October that its testing had found no asbestos in its baby powder after tests conducted by the US Food and Drug Administratio discovered trace amounts. 

The firm is appealing against a 2018 order to pay $4.7bn (£3.6bn) in damages to 22 women who alleged that its talc products caused them to develop ovarian cancer. (BBC)

LEAVE A REPLY

Please enter your comment!
Please enter your name here
Captcha verification failed!
CAPTCHA user score failed. Please contact us!

Related articles

Another B’s fire alarm

Fire fighters battled another huge fire at B’s Recycling, Cane Garden, St Thomas yesterday. Acting Divisional Officer of the...

Fire breaks out at B’s Recycling

A blaze has erupted at B's Recycling in Cane Garden, St. Thomas. More details as they come to hand....

BMS still monitoring dust haze

The Barbados Meteorological Services (BMS) continues to closely monitoring a large plume of dust haze in the eastern...

Brathwaite’s new venture reaps success

Ryan Brathwaite is no stranger to business. He's built a name for himself as the chief executive officer of...